NCT06487494

Brief Summary

This study aims to determine whether cyanoacrylate glue is a non-inferior alternative to continuous suturing for wound closure following adult circumcision. The primary objective of this study is to evaluate and compare operative time, pain, cosmesis, complications and patient satisfaction associated with the use of cyanoacrylate glue versus standard suturing for wound closure. To the best of our knowledge, this will be one of the first studies to investigate the use of cyanoacrylate glue for wound closure following adult circumcision. The findings from this study could provide valuable insights into the potential benefits of using cyanoacrylate glue as a non-inferior alternative to continuous suturing for wound closure. Additionally, this study may also inform clinical practice guidelines on the most effective techniques for wound closure following adult circumcision.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 5, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

August 26, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2025

Completed
Last Updated

September 5, 2025

Status Verified

July 1, 2024

Enrollment Period

12 months

First QC Date

June 27, 2024

Last Update Submit

August 29, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Cosmesis

    A cosmetic appearance satisfaction questionnaire will be administered at weeks 6 and 12 post-operation.

    6 and 12 weeks post-operation

  • Post-operative Pain

    Using a visual analogue pain scale \[range 0-10; 0 = no pain, 10 = maximal pain\], pain will be assessed as reported by the patient to determine their pain.

    Immediately post-operation and 6 weeks post-operation

  • Complication Rate

    Measuring and recording any adverse events post procedure such as surgical site infection, bleeding, hematoma, diffuse swelling, and increased sensitivity amidst intercourse.

    6 and 12 weeks post-operation

  • Intra-Operative Time

    Intra-operative time will be measured starting when the physician makes the first incision and ends when sutures are finished.

    During the operation

Study Arms (2)

2-octyl cyanoacrylate glue with four interrupted sutures

EXPERIMENTAL

In this arm the provider will use 2-octyl cyanoacrylate glue with four interrupted sutures for wound closing following circumcision.

Procedure: Circumcision wound closure using 2-octyl cyanoacrylate glue with four interrupted sutures

Continuous suture

ACTIVE COMPARATOR

In this arm the provider will use continuous suturing for wound closing following circumcision.

Procedure: Circumcision wound closure using continuous sutuing

Interventions

2-octyl cyanoacrylate glue is a wound closure adhesive which will be used with four interrupted sutures following circumcision for wound closure.

2-octyl cyanoacrylate glue with four interrupted sutures

Continuous suturing is the standard following circumcision for wound closure.

Continuous suture

Eligibility Criteria

Age16 Years - 80 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients \>16 years of age undergoing circumcision will be included.

You may not qualify if:

  • Patients \<16 years of age who did not provide consent to be randomized.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Men's Health Clinic Manitoba

Winnipeg, Manitoba, R3K 1M3, Canada

Location

MeSH Terms

Conditions

PhimosisParaphimosis

Condition Hierarchy (Ancestors)

Penile DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Department of Surgery. Director, Undergraduate Urologic Medical Education

Study Record Dates

First Submitted

June 27, 2024

First Posted

July 5, 2024

Study Start

August 26, 2024

Primary Completion

August 6, 2025

Study Completion

August 6, 2025

Last Updated

September 5, 2025

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations